Major CHD risk factors predominate among African-American women who are eligible for lipid-lowering drug therapy under the new ATP III guidelines
2004 ◽
Vol 11
(5)
◽
pp. 376-381
Keyword(s):
Chd Risk
◽
2007 ◽
Vol 197
(6)
◽
pp. S202
Keyword(s):
2002 ◽
Vol 17
(3)
◽
pp. 283-295
◽
2017 ◽
Vol 263
◽
pp. e236-e237
◽
Keyword(s):
2000 ◽
Vol 36
(5)
◽
pp. 1572-1578
◽
2012 ◽
Vol 31
(2)
◽
pp. 126-132
◽
Keyword(s):
2004 ◽
Vol 36
(Supplement)
◽
pp. S215???S216
2000 ◽
Vol 12
(1)
◽
pp. 13-20
◽
Keyword(s):